Thursday, October 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Almonty’s Tungsten Moment: A $1.2 Billion War Chest Meets a Market Still Finding Its Feet

Kennethcix by Kennethcix
September 6, 2026
in Analysis, Commodities, Nasdaq
0
Almonty Stock
0
SHARES
79
VIEWS
Share on FacebookShare on Twitter

The numbers orbiting Almonty Industries have become almost vertigo-inducing. Tungsten prices have climbed 622 percent between January 2025 and April 2026, according to the IEA. The company’s own revenue jumped 498 percent in the second quarter to $43.0 million, with mining operating income reaching $26.1 million. And yet the shares closed Friday at €15.17, down 1.2 percent on the day and roughly a quarter below their April peak of €20.61.

That gap between the headline momentum and the day-to-day price action captures the central tension now facing investors in the tungsten producer. The strategic story has rarely been more compelling — but the operational proof is still being written.

A Balance Sheet Transformed

Part of that story is financial. Almonty ended June with a cash position of C$1.2 billion, a dramatic leap from the C$268.4 million on hand at the end of December 2025. The jump traces back to a convertible bond completed in June that raised US$800 million, giving the company the firepower to fund the expansion of its Sangdong mine in South Korea and, by late August, to authorize a share buyback program of up to US$300 million.

The company has also reshaped where its shares trade. After voluntarily delisting from the Toronto Stock Exchange in late July, Almonty now lists solely on the Nasdaq under the ticker ALM and in Frankfurt as ALI1. The move shifts the center of gravity toward US capital markets, and the company’s late-June inclusion in the Russell 1000 and Russell 3000 indices should boost visibility among international institutional investors.

Analyst Validation Arrives

This week brought a fresh endorsement. Jefferies initiated coverage with a buy rating and a price target of $26.25, citing Almonty’s position in the build-out of Western tungsten supply chains. The rationale taps into a broader geopolitical shift: with 83 percent of global tungsten production coming from China, Western governments are increasingly treating the metal as strategic.

Should investors sell immediately? Or is it worth buying Almonty?

The policy tailwinds are hard to miss. Japan and the US reaffirmed their $550 billion trade agreement on Friday, with explicit attention to critical minerals and concerns over Chinese export controls. India, meanwhile, is pushing its own resource autonomy agenda through an eighth auction round covering 20 mineral blocks across nine states. Tungsten — essential for tools, defense, and electronics — has become emblematic of this supply-chain realignment.

The Sangdong Anchor

At the center of Almonty’s operational story sits Sangdong, where Phase I is targeting annual output of 640,000 tonnes of ore. The company recently extended its offtake agreement with Global Tungsten & Powders by more than 20 years, while increasing the contracted volume by 40 percent. Such long-term customer commitments carry particular weight in commodity cycles, offering pricing stability and decades of planning certainty.

The strategic positioning, however, only goes so far. The shares have climbed 320 percent over the past twelve months and 91 percent since the start of the year, with a 31 percent gain on a monthly basis. That kind of run — against a backdrop of 87 percent annualized volatility — leaves the stock vulnerable to consolidation, and the current 26 percent distance from the 52-week high reflects a market still digesting the move.

The Question That Remains

Investor forums are already debating whether the buyback is propping up the share price while the real value driver — the Sangdong ramp-up against persistently high tungsten prices — has yet to prove itself in the numbers. The next quarterly results, expected in roughly two months, should provide an empirical answer. Until then, US interest rate policy remains a risk factor that could pressure commodity stocks broadly, independent of their fundamental narratives.

The tungsten revival story is bigger than any single company. Almonty, with a producing mine, a fortified balance sheet, and a contract book extending decades into the future, has become its most visible embodiment. Whether that visibility translates into sustained shareholder value will depend on the operational execution that the coming quarters will reveal.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from October 22 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 22.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Kennethcix

Kennethcix

Related Posts

Shell Stock
Commodities

Shell’s Gas Ambitions Meet Buyback Discipline as LNG Canada Talks Take Shape

September 25, 2026
Micron Technology Stock
AI & Quantum Computing

Micron’s Rally Faces Its Moment of Reckoning: A Downgrade, a Labor Standoff, and a Date With the Numbers

September 9, 2026
Almonty Stock
Asian Markets

Almonty’s Double Play: A $300 Million Buyback Lands as Sangdong’s Stockpile Grows

September 7, 2026
Next Post
Wienerberger Stock

Wienerberger's Inner Circle Bets on a Recovery as Housing Slump Forces Steep Guidance Cut

Amphenol Stock

Amphenol's Post-Split Calm Belies a Clash Between Insider Caution and Analyst Conviction

Novo Nordisk Stock

Novo Nordisk's Oral Wegovy Push Hits Germany and China as the Bull-Bear Battle Widens

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com